CACH3; CACN4; CACNL1A2; CCHL1A2; Cav1.3; Voltage-gated calcium channel subunit alpha Cav1.3; Calcium channel, L type, alpha-1 polypeptide, isoform 2
CACH3; CACN4; CACNL1A2; CCHL1A2; Cav1.3; Voltage-gated calcium channel subunit alpha Cav1.3; Calcium channel, L type, alpha-1 polypeptide, isoform 2
CACNL1A3; CCHL1A3; Cav1.1; HOKPP; MHS5; hypoPP; DHPR; Dihydropyridine Receptor; Voltage-gated calcium channel subunit alpha Cav1.1
CACH2; CACN2; CACNL1A1; CCHL1A1; CaV1.2; TS; Voltage-gated calcium channel subunit alpha Cav1.2; Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle
CLIM2; NLI; Carboxy Terminal LIM Domain Protein 2; LIM domain-binding factor CLIM2; Nuclear LIM interactor
PINCH; PINCH1; Particularly interesting new Cys-His protein 1; Renal carcinoma antigen NY-REN-48
MLN50; Metastatic lymph node gene 50 protein
LMR3; TYKLM3; Serine/threonine-protein kinase LMTK3
CD171; L1-CAM; CAML1; HSAS; HSAS1; MASA; MIC5; N-CAML1; S10; SPG1; Antigen Identified By Monoclonal Antibody R1
CD171; L1-CAM; CAML1; HSAS; HSAS1; MASA; MIC5; N-CAML1; S10; SPG1; Antigen Identified By Monoclonal Antibody R1
CALL; L1CAM2; Neural Cell Adhesion Molecule; Cell Adhesion Molecule L1-Like
PCAF; P/CAF; GCN5; GCN5L; P300/CBP-Associated Factor; Histone acetyltransferase PCAF; Lysine acetyltransferase 2B